Kavar Capital Partners Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.59M | Buy |
3,904
+353
| +10% | +$358K | 0.45% | 55 |
|
|
2025
Q4 | $3.82M | Buy |
3,551
+11
| +0.3% | +$10.5K | 0.53% | 48 |
|
|
2025
Q3 | $2.7M | Buy |
3,540
+331
| +10% | +$246K | 0.36% | 63 |
|
|
2025
Q2 | $2.5M | Buy |
3,209
+396
| +14% | +$308K | 0.36% | 67 |
|
|
2025
Q1 | $2.32M | Buy |
2,813
+5
| +0.2% | +$4.16K | 0.39% | 64 |
|
|
2024
Q4 | $2.17M | Hold |
2,808
| – | – | 0.37% | 65 |
|
|
2024
Q3 | $2.49M | Sell |
2,808
-35
| -1% | -$31.5K | 0.39% | 64 |
|
|
2024
Q2 | $2.57M | Buy |
2,843
+25
| +0.9% | +$20K | 0.46% | 60 |
|
|
2024
Q1 | $2.19M | Buy |
2,818
+1,920
| +214% | +$1.37M | 0.4% | 64 |
|
|
2023
Q4 | $523K | Sell |
898
-53
| -6% | -$30.9K | 0.06% | 130 |
|
|
2023
Q3 | $511K | Hold |
951
| – | – | 0.11% | 106 |
|
|
2023
Q2 | $446K | Buy |
951
+231
| +32% | +$96.9K | 0.1% | 105 |
|
|
2023
Q1 | $247K | Hold |
720
| – | – | 0.05% | 136 |
|
|
2022
Q4 | $263K | Buy |
720
+60
| +9% | +$21.3K | 0.06% | 123 |
|
|
2022
Q3 | $213K | Hold |
660
| – | – | 0.05% | 132 |
|
|
2022
Q2 | $214K | Buy |
+660
| New | +$198K | 0.05% | 153 |
|
|
2019
Q3 | – | Sell |
-500
| Closed | -$55K | – | 317 |
|
|
2019
Q2 | $55K | Buy |
+500
| New | +$58.9K | 0.02% | 220 |
|
|
2018
Q3 | – | Sell |
-100
| Closed | -$9K | – | 266 |
|
|
2018
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 325 |
|
|
2018
Q1 | $8K | Buy |
+100
| New | +$8.05K | ﹤0.01% | 337 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$8K | – | 252 |
|
|
2015
Q4 | $8K | Hold |
100
| – | – | 0.01% | 279 |
|
|
2015
Q3 | $8K | Sell |
100
-100
| -50% | -$8.44K | 0.01% | 290 |
|
|
2015
Q2 | $16K | Buy |
+200
| New | +$15.2K | 0.01% | 264 |
|
Other funds holding LLY
VCM
VPM
